Nov. 12 Quick Takes: MorphoSys, UCB bring in new tech via deals; plus Cevec-Roche, Bridge-BI, Affimed-Roivant, Insilico-J&J, TCR2-ElevateBio

By STEPHEN HANSEN, ASSOCIATE EDITOR AND JEFF CRANMER, EXECUTIVE EDITOR

Nov 13, 2020 | 3:36 AM GMT

A Cherry in MorphoSys’ hunt for new tech
MorphoSys AG (Xetra:MOR; NASDAQ:MOR) entered an exclusive licensing agreement with University Hospital Würzburg spinout